ABSTRACT Introduction: Osteoarticular fungal infections (OAFIs) complicate the clinical
course of high-risk patients, including immunosuppressed individuals. Their management …

Introduction: Fungal osteoarticular/soft tissue infections (FOaSI) are an uncommon entity
with protracted course due to variability in clinical picture, slow progression; resulting in …

Management of fungal osteomyelitis and fungal septic arthritis is challenging, especially in
the setting of immunodeficiency and conditions that require immunosuppression. Because …

Osteoarticular complications may occur with a variety of invasive fungal infections, and seem
to be increasing with growing use of prosthetic joints and as the immunosuppressed patient …

Fungal osteomyelitis is a severe and debilitating disease, affecting both immunocompetent
and immunocompromised patients. Recent comprehensive reviews showed that the burden …

Fungal osteomyelitis is considered a rare disease, and the published literature mainly
comprises case reports, case series and narrative reviews. A systematic review was …

Haematological malignancies are known to be significant risk factors for invasive fungal
infections (IFIs), 1 particularly in high-income countries. Multiple myeloma, a common …

Osteoarticular mycoses are chronic debilitating infections that require extended courses of
antifungal therapy and may warrant expert surgical intervention. As there has been no …

There has been an increasing incidence of fungal infections in recent years. Rarely joints
are also affected by fungal infections. Mainly, these infections develop in prosthetic joints …

Background: Current guidelines for treatment of Candida osteoarticular infections (COAIs)
recommend a prolonged course of antifungal therapy (AFT) of 6–12 months. Based upon …